A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein a induces protective responses against Streptococcus pneumoniae

Infection and Immunity

Volumn 66, Issue 8, 1998, Pages 3744-3751

  Nayak, Amiya R ^a   Tinge, Steven A ^a,b   Tart, Rebecca C ^c,d   McDaniel, Larry S ^c,e   Briles, David E ^c   Curtiss III, Roy ^a,f  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Megan Health Inc   (United States)

^c University of Alabama at Birmingham   (United States)

^d CAMPBELL UNIVERSITY   (United States)

^e UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^f WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; DIAMINOPIMELIC ACID; MEMBRANE PROTEIN; PROTEIN A; RECOMBINANT VACCINE; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; GENE MUTATION; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS PNEUMONIA;

SALMONELLA;

EID: 0031823629     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.8.3744-3751.1998     Document Type: Article

References (46)

1. Austrian, R. A. 1984. Pneumococcal infections, p. 257-288. In R. Germanier (ed.), Bacterial vaccines. Academic Press, Inc., New York, N.Y.
2. Benton, K. A., M. P. Everson, and D. E. Briles. 1995. A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice. Infect. Immun. 63:448-455.
3. Benton, K. A., J. C. Paton, and D. B. Briles. 1997. Differences in virulence of mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production. Infect. Immun. 65:1237-1244.
4. Briles, D. E., J. D. King, M. A. Gray, L. S. McDaniel, E. Swiatlo, and K. A. Benton. 1996. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 14:858-867.
5. Briles, D. E., R. C. Tart, E. Swiatlo, J. P. Dillard, P. Smith, K. A. Benton, A. Brooks-Walter, M. J. Crain, S. K. Hollingshead, and L. S. McDaniel. Pneumococcal diversity: considerations for new vaccine strategies with an emphasis on pneumococcal surface protein A. (PspA). Clin. Microbiol. Rev., in press.
6. Briles, D. E., R. C. Tart, H.-Y. Wu, B. A. Ralph, M. W. Russell, and L. S. McDaniel. 1996. Systemic and mucosal protective immunity to pneumococcal surface protein A. Ann. N. Y. Acad. Sci. 797:118-126.
7. Brockman, R. E., and L. A. Heppel. 1968. On the localization of alkaline phosphatase and cyclic phosphodiesterase in Escherichia coli. Biochemistry 7:2554-2562.
8. Cardenas, L., and J. D. Clements. 1993. Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors. Vaccine 11:126-135.
9. Crain, M. J., W. D. Waltman II, J. S. Turner, J. Yother, D. E. Talkington, L. S. McDaniel, B. M. Gray, and D. E. Briles. 1990. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect. Immun. 58:3293-3299.
10. Curtiss, R., III. 1990. Antigen delivery systems for analyzing host immune responses and for vaccine development. Trends Biotechnol. 8:237-240.
11. Curtiss, R., III. 1990. Attenuated Salmonella strains as live vectors for the expression of foreign antigens, p. 161-188. In G. C. Woodrow and M. M. Levine (ed.), New generation vaccines. Marcel Dekker, New York, N.Y.
12. Curtiss, R., III, and S. M. Kelly. 1987. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 55:3035-3043.
13. Curtiss, R., III, S. M. Kelly, P. A. Gulig, and K. Nakayama. 1989. Selective delivery of antigens by recombinant bacteria. Curr. Top. Microbiol. Immunol. 146:35-49.
14. Ellis, R. W., and G. J. Douglas. 1994. New vaccine technologies. JAMA 271: 929-931.
15. Hazerbaurer, G. L., and S. Harayama. 1979. Mutants in transmission of chemotactic signals from two independent receptors of Escherichia coli. Cell 16:617-625.
16. Henrichsen, J. 1995. Six newly recognized types of Streptococcus pneumoniae. J. Clin. Microbiol. 33:2759-2762.
17. Janoff, E. N., J. O'Brien, P. Thompson, J. Ehret, G. Meiklejohn, G. Duvall, and J. M. J. Douglass. 1993. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J. Infect. Dis. 167:49-56.
18. Jernigan, D. B., M. S. Cetron, and R. F. Breiman. 1996. Defining the public health impact of drug resistant Streptococcus pneumoniae: report of a working group. Morbid. Mortal. Weekly Rep. 45:1-20.
19. Langermann, S., S. R. Palaszynski, J. E. Burlein, S. Koenig, M. S. Hanson, D. E. Briles, and C. K. Stover. 1994. Protective humoral response against pneumococcal infection in mice elicited by recombinant Bacille Calmette-Guérin vaccines expressing PspA. J. Exp. Med. 180:2277-2286.
20. Luria, S. E., and J. W. Burrous. 1957. Hybridization between Escherichia coli and Shigella. J. Bacteriol. 74:461-476.
21. Marrie, T. J. 1994. Community-acquired pneumonia. Clin. Infect. Dis. 18: 501-515.
22. McDaniel, L. S., B. A. Ralph, D. O. McDaniel, and D. E. Briles. 1994. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. Microb. Pathog. 17:323-337.
23. McDaniel, L. S., G. Scott, J. F. Kearney, and D. E. Briles. 1984. Monoclonal antibodies against protease sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J. Exp. Med. 160: 386-397.
24. McDaniel, L. S., G. Scott, K. Widenhofer, J. M. Carroll, and D. E. Briles. 1986. Analysis of a surface protein of Streptococcus pneumoniae recognized by protective monoclonal antibodies. Microb. Pathog. 1:519-531.
25. McDaniel, L. S., J. S. Sheffield, P. Delucchi, and D. E. Briles. 1991. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. Infect. Immun. 59: 222-228.
26. McDaniel, L. S., J. S. Sheffield, E. Swiatlo, J. Yother, M. J. Crain, and D. E. Briles. 1992. Molecular localization of variable and conserved regions of pspA, and identification of additional pspA homologous sequences in Streptococcus pneumoniae. Microb. Pathog. 13:261-269.
27. + expression vector: stable maintenance and high expression of cloned genes in a Salmonella vaccine strain. Bio/Technology 6:693-697.
28. Neu, H. C. 1992. The crisis in antibiotic resistance. Science 257:1064-1073.
29. Paton, J., P. Andrew, G. Boulnois, and T. Mitchell. 1993. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu. Rev. Microbiol. 47:89-115.
30. Roberts, M., S. N. Chatfield, and G. Dougan. 1994. Salmonella as carriers of heterologous antigens, p. 27-58. In D. T. O'Hagen (ed.), Novel delivery systems for oral vaccines. CRC Press, Inc., Boca Raton, Fla.
31. Roberts, R. B. 1985. Streptococcus pneumoniae, p. 1142-1152. In G. L. Mandell, R. G. Douglas, and J. E. Bennet (ed.), Infectious diseases and their agents. John Wiley & Sons, New York, N.Y.
32. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p. E.3. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
33. Schödel, F. 1992. Prospects for oral vaccination using recombinant bacteria expressing viral epitopes. Adv. Virus Res. 41:409-446.
34. Schödel, F., S. M. Kelly, D. L. Peterson, D. R. Milich, and R. Curtiss III. 1994. Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infect. Immun. 62:1669-1676.
35. Shapiro, E. D., A. T. Berg, R. Austrian, D. Schroeder, V. Parcells, A. Margolis, R. K. Adair, and J. D. Clemmens. 1991. Protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325:1453-1460.
36. Siber, G. R. 1994. Pneumococcal disease: prospects for a new generation of vaccines. Science 265:1385-1387.
37. Srinivasan, J., A. Nayak, R. Curtiss III, and S. Rubino. 1995. Effect of the route of immunization using recombinant Salmonella on mucosal and humoral immune responses, p. 273-280. In R. M. Chanock, F. Brown, H. S. Ginsberg, and E. Norrby (ed.), Molecular approaches to the control of infectious diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
38. Talkington, D. F., D. L. Crimmins, D. C. Voellinger, J. Yother, and D. E. Briles. 1991. A 43-kilodalton pneumococcal surface protein, PspA: isolation, protective abilities, and structural analysis of the amino-terminal sequence. Infect. Immun. 59:1285-1289.
39. Talkington, D. F., D. C. Voellinger, L. S. McDaniel, and D. E. Briles. 1992. Analysis of pneumococcal PspA microheterogeneity in SDS polyacrylamide gels and the association of PspA with the cell membrane. Microb. Pathog. 13: 343-355.
40. Tart, R. C., L. S. McDaniel, B. A. Ralph, and D. E. Briles. 1996. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice. J. Infect. Dis. 173:380-386.
41. Waltman, W. D., II, L. S. McDaniel, B. M. Gray, and D. E. Briles. 1990. Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae. Microb. Pathog. 8:61-69.
42. Wu, H.-Y., M. Nahm, Y. Guo, M. Russell, and D. E. Briles. 1997. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage and infection with Streptococcus pneumoniae. J. Infect. Dis. 175:839-846.
43. Yamamoto, M., L. S. McDaniel, K. Kawabata, D. E. Briles, R. J. Jackson, J. R. McGhee, and H. Kiyono. 1997. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection. Infect. Immun. 65:640-644.
44. Yother, J., and D. E. Briles. 1992. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J. Bacteriol. 174:601-609.
45. Yother, J., G. L. Handsome, and D. E. Briles. 1992. Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene. J. Bacteriol. 174:610-618.
46. Yother, J., and J. M. White. 1994. Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA. J. Bacteriol. 176:2976-2985.